HOME




Wednesday, 8 September 2010
Novogen agrees to sell its Intellectual Property Portfolio to its subsidiary Marshall Edwards

More news

 




Boardroom Radio






About Novogen | Knowledge Base | Consumer Health | Pharmaceuticals | News | Investor Relations | Contact | Site Map
Copyright © 2010 Novogen The world leader in isoflavone research - with products including Promensil and Trinovin | Web Design by Newgency